Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development ofatherosclerosis
M. Kaplan et al., Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development ofatherosclerosis, J NUTR, 131(8), 2001, pp. 2082-2089
Inhibition of lipid peroxidation contributes to the attenuation of macropha
ge cholesterol accumulation, foam-cell formation and atherosclerosis. Evide
nce suggests that nutritional antioxidants such as pomegranate juice (PJ) c
an contribute to the reduction of oxidative stress and atherogenesis. The g
oals of the present study were to determine whether such beneficial effects
of PJ exist when supplemented to apolipoprotein E-deficient (E degrees) mi
ce with advanced atherosclerosis and to analyze the antiatherosclerotic act
ivity of a tannin-fraction isolated from PJ. Mice (4-mo-old) were supplemen
ted with PJ in their drinking water for 2 mo and compared with age-matched
placebo-treated mice, as well as to young (4-mo-old) control mice, for thei
r mouse peritoneal macrophage (MPM) oxidative state, cholesterol flux and m
ice atherosclerotic lesion size. PJ supplementation reduced each of the pro
atherogenic variables determined in the present study compared with age-mat
ched placebo-treated mice. It significantly induced serum paraoxonase activ
ity and reduced MPM lipid peroxide content compared with placebo-treated mi
ce and control mice. PJ administration to E degrees mice significantly redu
ced the oxidized (Ox)-LDL MPM uptake by 31% and MPM cholesterol esterificat
ion and increased macrophage cholesterol eff lux by 39% compared with age-m
atched, placebo-treated mice. PJ consumption reduced macrophage Ox-LDL upta
ke and cholesterol esterification to levels lower than those in 4-mo-old, u
nsupplemented controls. PJ supplementation to E degrees mice with advanced
atherosclerosis reduced the lesion size by 17% compared with placebo-treate
d mice. In a separate study, supplementation of young (2-mo-old) E degrees
mice for 2 mo with a tannin fraction isolated from PJ reduced their atheros
clerotic lesion size, paralleled by reduced plasma lipid peroxidation and d
ecreased Ox-LDL MPM uptake. PJ supplementation to mice with advanced athero
sclerosis reduced their macrophage oxidative stress, their macrophage chole
sterol flux and even attenuated the development of atherosclerosis. Moreove
r, a tannin-fraction isolated from PJ had a significant antiatherosclerotic
activity.